CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...